The Evolving Landscape of Checkpoint Inhibitor Combination Therapy in the Treatment of Advanced Hepatocellular Carcinoma
Lin Liu, Shukui Qin, Yu Zhang
Topics & Concepts
MedicineRegorafenibRamucirumabSorafenibAtezolizumabLenvatinibNivolumabCabozantinibPembrolizumabHepatocellular carcinomaOncologyTargeted therapyInternal medicineClinical trialCombination therapyCancerImmunotherapyColorectal cancerHepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and TherapyFerroptosis and cancer prognosis